Not really, fomenting is against the law and if found guilty you are liable.
Zero, longs selling long positions do not make shares available to short.
IF a long sells 1,000,000 shares of his stock at interactive brokers, those shares do not become available to short at IB. They went to a new buyers, someone else and chances are they were not at IB and did those shares go into a margin account or a cash account? In a Cash account they would not be made available for borrowing.
However, if someone buys 1,000,000 shares in a margin account and those could be made available to short at the fim, I state could be.
I am an advocate for not using sell stops especially with volatile stocks. We are not going to see 50 bucks a share for a very long time and a lot has to happen to drive us there.
At 50 bucks a share we would have a Market Cap of over 11 Billion dollars. We will need a lot more revenue to drive a market cap that high.
They are pleased with the quarter over quarter growth of the scripts. That is the right time frame to be watching. Week over week is what the traders and game players want the retail to focus on.
You have a very misplaced sense of bravery and courage that only the internet allows you to have. Try adding something of value to the discussion and stop being so childish.
Scripts were coming out and Arena was doing a dog and pony. I think many thought the script could pop up or that Arena might release something new. So far none of that has happened.
So longs that post facts are pumpers and bashers telling lies and mis stating facts, or throwing opinion out are just being real and helpful to the longs .... Looking out for our investments, how kind of them .
It is a dog and pony show and it is not to raise money but to raise awareness about Arena, Belviq and its pipeline. They are trying to build broker and money manager support. That brings stability to the stock and awareness to what is really going on at Arena. It is called a break out session and the attendees will have a couple choices during the time window to choose from.
I am sure they will talk about some of the non clinical Bel Phen findings but remember it is Eisais safety study. The results will probably come from a PR from Eisai when the time comes.
Not sure the purchase of Eisai with all their baggage is a good thing. Even if they wanted Lorcaerin in a very bad way buying Eisai might make it an unappealing deal.
Almost feels like they covered a little let the stock run back up and then shorted again into the buying volume. We won't know that tho until the report ending 9/30/14 is out 10 days later
That story is not translating yet to the exponential script growth. It is going to take a little while longer to cook this goose... Slow perk.